2023 - NCI Bottom Line: A Blog about Grants and More

A magnifying glass with a bar graph and line graph inside

NCI's Fiscal Year 2024 Budget Challenges and Interim Paylines Explained

November 15, 2023, by NCI Acting Director, Dr. Douglas R. Lowy

NCI faces significant challenges while operating under a continuing resolution for fiscal year 2024. In this edition of the Bottom Line, NCI Acting Director Dr. Lowy highlights the impact of this “flat” budget on NCI’s ability to support cancer research and shares fiscal year 2024 interim paylines for competing grants.

A silhouette of a scientist looking into a microscope.

Leading Progress against Cancer: NCI’s Fiscal Year 2025 Professional Judgment Budget Proposal

September 27, 2023, by Director, Center for Research Strategy, Dr. Diane Palmieri

The National Cancer Institute Fiscal Year 2025 Professional Judgment Budget Proposal highlights how, with optimal funding, NCI will support cancer research, train future cancer researchers, and expand and maintain research infrastructure to achieve the goal of ending cancer as we know it for all. In this edition, Dr. Diane Palmieri discusses NCI’s proposal to increase funding to support more meritorious cancer research and spotlights one of the five scientific opportunities, the Cancer Research Data Ecosystem, where increased funding will spur advances.

Photo of the Frederick National Laboratory for Cancer Research.

Resources from the Frederick National Laboratory for Cancer Research

August 3, 2023, by NCI Director Dr. Monica Bertagnolli

In this edition of the NCI Bottom Line blog, Dr. Bertagnolli highlights resources available to researchers from the Frederick National Laboratory for Cancer Research (FNLCR). From cryo-electron microscopy to the RAS Initiative, FNLCR offers a variety of tools for the scientific community to propel research progress and enable breakthroughs.

A younger man and older woman in a laboratory looking at a screen together.

NCI’s Sustained Funding and Engagement for Mentored Cancer Researchers

July 10, 2023, by Dr. Oliver Bogler

NCI remains strongly committed to developing the cancer research workforce. In this edition of the NCI Bottom Line blog, Dr. Bogler discusses trends in funding for cancer training and highlights two new resources from the Center for Cancer Training to help the research community stay informed and engaged.

Group of scientists having a meeting in a laboratory

NCI Encourages More Collaborative Research to Accelerate Cancer Science

April 13, 2023, by Drs. Phil Castle, Jim Doroshow, Dan Gallahan, Katrina Goddard, and Toby Hecht

In this edition of the NCI Bottom Line blog, NCI leaders encourage diverse teams of researchers collaborating around a unifying scientific goal to consider applying for a program project grant (P01). P01 grants involve the type of broad, multidisciplinary collaboration likely to yield meaningful results for cancer science and patients.

Cancer Grand Challenges partnership image

Cancer Grand Challenges Invites Global Teams to Submit Research Proposals

April 6, 2023, by Dr. Douglas R. Lowy and Dr. Dinah S. Singer, NCI Deputy Directors

In this edition of the NCI Bottom Line blog, NCI Deputy Directors Drs. Lowy and Singer discuss the new round of nine research challenges from the Cancer Grand Challenges program. Cancer Grand Challenges aims to inspire bold new ideas that offer the greatest potential to advance cancer research and improve outcomes for people affected by cancer. In 2024, up to four interdisciplinary teams will each receive about $25 million across five years to conduct their research.

Four individuals gathered around a table in an office setting discussing data displayed on a tablet, surrounded by printed charts and graphs.

NCI Funds More Research Grants Thanks to Action by Congress

February 6, 2023, by NCI Director Dr. Monica Bertagnolli

In this edition of the Bottom Line blog, NCI Director Dr. Monica Bertagnolli explains how generous support from Congress will allow NCI to award more compelling cancer research and to increase paylines for R01s and early-stage investigator (ESI) grants. In fiscal year 2023, NCI expects to issue more than 100 additional R01 and ESI awards than last year.